Andrés J. Muñoz Martín
YOU?
Author Swipe
View article: Correction: PARP inhibitors‑associated thrombosis in patients with ovarian cancer: a study of the Spanish Society of Medical Oncology (SEOM) thrombosis and cancer group
Correction: PARP inhibitors‑associated thrombosis in patients with ovarian cancer: a study of the Spanish Society of Medical Oncology (SEOM) thrombosis and cancer group Open
View article: Gut microbiome and nutritional strategies in gastrointestinal cancers: Clinical implications and therapeutic perspectives
Gut microbiome and nutritional strategies in gastrointestinal cancers: Clinical implications and therapeutic perspectives Open
Gastrointestinal malignancies, particularly pancreatobiliary and gastroesophageal cancers, are associated with poor prognosis due to their frequent late-stage diagnosis. Many of these tumors contribute to anorexia-cachexia syndrome and mal…
View article: Multidisciplinary consensus on the management of patients with osteopenia and fracture risk in Spain
Multidisciplinary consensus on the management of patients with osteopenia and fracture risk in Spain Open
View article: An Unusual Reason for Pacemaker Implantation in a Young Woman
An Unusual Reason for Pacemaker Implantation in a Young Woman Open
View article: PARP inhibitors-associated thrombosis in patients with ovarian cancer: a study of the Spanish Society of Medical Oncology (SEOM) thrombosis and cancer group
PARP inhibitors-associated thrombosis in patients with ovarian cancer: a study of the Spanish Society of Medical Oncology (SEOM) thrombosis and cancer group Open
BRCA2 mutations could be a significant predictor for VTE/AT among ovarian cancer patients treated with iPARP. Concomitant treatment with bevacizumab may offer protection against thrombotic events, although a concomitant bias cannot be rule…
View article: Corrigendum: Management of Cancer-Associated Thrombosis: Unmet Needs and Future Perspectives
Corrigendum: Management of Cancer-Associated Thrombosis: Unmet Needs and Future Perspectives Open
[This corrects the article DOI: 10.1055/s-0041-1736037.].
View article: 27P Study of tumor mutational variation measured by NGS in patients with BRAF-mutated metastatic colorectal cancer undergoing surgery after prior systemic treatment
27P Study of tumor mutational variation measured by NGS in patients with BRAF-mutated metastatic colorectal cancer undergoing surgery after prior systemic treatment Open
View article: 290P Impact of the systemic inflammation index (SIRI) and artificial intelligence(AI)-based muscle mass (FocusedON® software) on chemotherapy toxicity and prognosis in metastatic pancreatic cancer: A proof-of-concept from the PANTHEIA-Spanish Society of Medical Oncology (SEOM) study group
290P Impact of the systemic inflammation index (SIRI) and artificial intelligence(AI)-based muscle mass (FocusedON® software) on chemotherapy toxicity and prognosis in metastatic pancreatic cancer: A proof-of-concept from the PANTHEIA-Spanish Society of Medical Oncology (SEOM) study group Open
View article: 289P Prognostic significance of the systemic inflammation response index (SIRI) and nutritional status in metastatic pancreatic cancer: Results from the PANTHEIA–SEOM study
289P Prognostic significance of the systemic inflammation response index (SIRI) and nutritional status in metastatic pancreatic cancer: Results from the PANTHEIA–SEOM study Open
View article: MDM2 amplification in a real-world cohort of patients with biliary tract cancer from the Spanish RETUD gastrointestinal registry
MDM2 amplification in a real-world cohort of patients with biliary tract cancer from the Spanish RETUD gastrointestinal registry Open
Background: Antagonist of mouse double minute 2 homolog (MDM2) represents a novel therapeutic strategy in biliary tract cancer (BTC). We aimed to characterize the epidemiology of MDM2 amplifications in patients with BTC, associations of MD…
View article: External validation of a prediction model for bleeding events in anticoagulated cancer patients with venous thromboembolism (PredictAI)
External validation of a prediction model for bleeding events in anticoagulated cancer patients with venous thromboembolism (PredictAI) Open
View article: Derivation and validation of the Caravaggio score for the risk stratification for recurrence in patients with cancer-associated venous thromboembolism
Derivation and validation of the Caravaggio score for the risk stratification for recurrence in patients with cancer-associated venous thromboembolism Open
The Caravaggio score is simple and able to stratify patients with CAT for the risk for VTE recurrence.
View article: State of the art of the molecular hyperselection to guide treatment with anti-EGFR antibodies in RAS WT mCRC: implications for clinical practice and future perspectives
State of the art of the molecular hyperselection to guide treatment with anti-EGFR antibodies in RAS WT mCRC: implications for clinical practice and future perspectives Open
Negative hyperselection beyond RAS and BRAF in advanced colorectal cancer appears to be a powerful tool for predicting outcomes to anti-EGFR therapy and spare patients from unnecessary treatment. This improvement appears in both naïve and …
View article: Real-world management and outcome of patients with pancreatic adenocarcinoma. Results of the Spanish RETUD gastrointestinal registry
Real-world management and outcome of patients with pancreatic adenocarcinoma. Results of the Spanish RETUD gastrointestinal registry Open
Background: Patient registries better reflect real-world management and outcomes of pancreatic cancer (PC) compared with clinical trials. Patients and methods: The main objective was to characterize patterns of care and outcomes in patient…
View article: Soluble TIM-3, likely produced by myeloid cells, predicts resistance to immune checkpoint inhibitors in metastatic clear cell renal cell carcinoma
Soluble TIM-3, likely produced by myeloid cells, predicts resistance to immune checkpoint inhibitors in metastatic clear cell renal cell carcinoma Open
Background Immunotherapies targeting PD-1 and CTLA-4 are key components of the treatment of metastatic clear cell renal cell carcinoma (mccRCC). However, they have distinct safety profiles and resistance to treatment can occur. We assess s…
View article: Manejo avanzado de las complicaciones tromboembólicas en los pacientes con tumores sólidos y hematológicos
Manejo avanzado de las complicaciones tromboembólicas en los pacientes con tumores sólidos y hematológicos Open
La trombosis asociada con cáncer es una complicación común de la propia enfermedad, lo que implica mayor riesgo de mortalidad y morbilidad en esta población. El tratamiento anticoagulante también conlleva dificultades relacionadas con el r…
View article: Maintenance chemotherapy in biliary tract tumours in the era of immuno-chemotherapy
Maintenance chemotherapy in biliary tract tumours in the era of immuno-chemotherapy Open
Biliary tract tumours (BTCs) are malignancies with a poor prognosis. Regarding first-line therapy options, cisplatin and gemcitabine (CisGem) alone has been the standard therapy option for more than a decade. This has changed recently, due…
View article: Immunotherapy in hepatocellular carcinoma
Immunotherapy in hepatocellular carcinoma Open
View article: Cancer-related thrombosis: impact of biological sex on the risk of rethrombosis and bleeding
Cancer-related thrombosis: impact of biological sex on the risk of rethrombosis and bleeding Open
Patients with cancer present a higher risk of rethrombosis and bleeding secondary to anticoagulant treatment than individuals without cancer. Given the lack of specific clinical trials, the decision regarding the optimal duration of treatm…
View article: Correction: Prediction model for major bleeding in anticoagulated patients with cancer-associated venous thromboembolism using machine learning and natural language processing
Correction: Prediction model for major bleeding in anticoagulated patients with cancer-associated venous thromboembolism using machine learning and natural language processing Open
View article: Soluble TIM-3, likely produced by myeloid cells, predicts resistance to immune checkpoint inhibitors in metastatic clear cell renal cell carcinoma
Soluble TIM-3, likely produced by myeloid cells, predicts resistance to immune checkpoint inhibitors in metastatic clear cell renal cell carcinoma Open
Background and objectives Immunotherapies targeting PD-1 and CTLA-4 are key components of the treatment of metastatic clear cell renal cell carcinoma (mccRCC). However, they have distinct safety profiles and resistance to treatment can occ…
View article: Catheter – related thrombosis in cancer patients: Data from the registry of thrombosis and nEoplasia of SEOM (TESEO)
Catheter – related thrombosis in cancer patients: Data from the registry of thrombosis and nEoplasia of SEOM (TESEO) Open
Background: Catheter related thrombosis (CRT) is the most frequent non-infectious complication associated with central venous access devices (CVAD), with a reported incidence between 13 % and 66 % in symptomatic and asymptomatic patients, …
View article: Prediction model for major bleeding in anticoagulated patients with cancer-associated venous thromboembolism using machine learning and natural language processing
Prediction model for major bleeding in anticoagulated patients with cancer-associated venous thromboembolism using machine learning and natural language processing Open
Purpose We developed a predictive model to assess the risk of major bleeding (MB) within 6 months of primary venous thromboembolism (VTE) in cancer patients receiving anticoagulant treatment. We also sought to describe the prevalence and i…
View article: Update in venous thromboembolism in cancer: Lessons from multi-centre registries
Update in venous thromboembolism in cancer: Lessons from multi-centre registries Open
Cancer-associated thrombosis is a common problem in cancer patients and one of the leading causes of death in this population. Randomised clinical trials have shown that both low-molecular-weight heparins and direct oral anticoagulants are…
View article: Immune checkpoint inhibitors-associated thrombosis in patients with head and neck cancer: a study of the Spanish society of medical oncology (SEOM) thrombosis and cancer group
Immune checkpoint inhibitors-associated thrombosis in patients with head and neck cancer: a study of the Spanish society of medical oncology (SEOM) thrombosis and cancer group Open
Purpose Both venous and arterial thrombotic events (VTE/AT) can be associated with Immune Checkpoint Inhibitors (ICI). However, there is a paucity of information apropos patients in routine clinical practice. Methods /Patients. This retros…
View article: #1698526 A Case of Thyroid Eye Disease in a Hypothyroid Patient
#1698526 A Case of Thyroid Eye Disease in a Hypothyroid Patient Open
View article: Improvement of thrombosis management in patients with cancer: a practical consensus document of recommendations for cancer-associated thrombosis patients’ healthcare in Spain
Improvement of thrombosis management in patients with cancer: a practical consensus document of recommendations for cancer-associated thrombosis patients’ healthcare in Spain Open
View article: Systemic Inflammation Response Index and weight loss as prognostic factors in metastatic pancreatic cancer: A concept study from the PANTHEIA-SEOM trial
Systemic Inflammation Response Index and weight loss as prognostic factors in metastatic pancreatic cancer: A concept study from the PANTHEIA-SEOM trial Open
BACKGROUND The prognostic value of the Systemic Inflammation Response Index (SIRI) in advanced pancreatic cancer is recognized, but its correlation with patients´ nutritional status and outcomes remains unexplored. AIM To study the prognos…
View article: Early Time Courses of Recurrent Venous Thromboembolism and Bleeding during Apixaban or Dalteparin Therapy for Patients with Cancer
Early Time Courses of Recurrent Venous Thromboembolism and Bleeding during Apixaban or Dalteparin Therapy for Patients with Cancer Open
Background In patients with acute venous thromboembolism (VTE), the rates of recurrence and major bleeding are highest during the first weeks of anticoagulation. The CARAVAGGIO trial demonstrated noninferiority of apixaban to dalteparin fo…
View article: Catheter – Related Thrombosis in Cancer Patients: Data from the Registry of Thrombosis and Neoplasia of Seom (Teseo)
Catheter – Related Thrombosis in Cancer Patients: Data from the Registry of Thrombosis and Neoplasia of Seom (Teseo) Open